MariaTeresa Giordani

Dr. MariaTeresa Giordani

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2016 in Nature Communications
Verified
Journal Article
Open access
BWBonnie van Wilgenburg
Bonnie van Wilgenburg
ISIris Scherwitzl
Iris Scherwitzl
EHEdward Hutchinson
Edward Hutchinson
TLTianqi Leng
Tianqi Leng
AKAyako Kurioka
Ayako Kurioka
PKPaul Klenerman
Paul Klenerman
Mucosal-associated invariant T (MAIT) cells are abundant in humans and recognize bacterial ligands. Here, we demonstrate that MAIT cells are also activated during human viral infections in vivo. MAIT cells activation was observed during infection with dengue virus, hepatitis C virus and influenza virus. This activation—driving cytokine release and Granzyme B upregulation—is TCR-independent but dependent on IL-18 in synergy with IL-12, IL-15 and/or interferon-α/β. IL-18 levels and MAIT cell activation correlate with disease severity in acute dengue infection. Furthermore, HCV treatment with interferon-α leads to specific MAIT cell activation in vivo in parallel with an enhanced therapeutic response. Moreover, TCR-independent activation of MAIT cells leads to a reduction of HCV replication in vitro mediated by IFN-γ. Together these data demonstrate MAIT cells are activated following viral infections, and suggest a potential role in both host defence and immunopathology.

1 May 2006 in Gastroenterology
Verified
Journal Article
Open access
PDF file
GLGioacchino Leandro
Gioacchino Leandro
Alessandra MangiaAlessandra Mangia
Alessandra Mangia
JHJason Hui
Jason Hui
PFPaolo Fabris
Paolo Fabris
LRLaura Rubbia–Brandt
Laura Rubbia–Brandt
FNFrancesco Negro
Francesco Negro
Background & Aims: Steatosis is a frequent histologic finding in chronic hepatitis C (CHC), but it is unclear whether steatosis is an independent predictor for liver fibrosis. We evaluated the association between steatosis and fibrosis and their common correlates in persons with CHC and in subgroup analyses according to hepatitis C virus (HCV) genotype and body mass index. Methods: We conducted a meta-analysis on individual data from 3068 patients with histologically confirmed CHC recruited from 10 clinical centers in Italy, Switzerland, France, Australia, and the United States. Results: Steatosis was present in 1561 patients (50.9%) and fibrosis in 2688 (87.6%). HCV genotype was 1 in 1694 cases (55.2%), 2 in 563 (18.4%), 3 in 669 (21.8%), and 4 in 142 (4.6%). By stepwise logistic regression, steatosis was associated independently with genotype 3, the presence of fibrosis, diabetes, hepatic inflammation, ongoing alcohol abuse, higher body mass index, and older age. Fibrosis was associated independently with inflammatory activity, steatosis, male sex, and older age, whereas HCV genotype 2 was associated with reduced fibrosis. In the subgroup analyses, the association between steatosis and fibrosis invariably was dependent on a simultaneous association between steatosis and hepatic inflammation. Conclusions: In this large and geographically different group of CHC patients, steatosis is confirmed as significantly and independently associated with fibrosis in CHC. Hepatic inflammation may mediate fibrogenesis in patients with liver steatosis. Control of metabolic factors (such as overweight, via lifestyle adjustments) appears important in the management of CHC.

1 March 2004 in Journal of Clinical Virology
Verified
Journal Article
Closed access
PFPaolo Fabris
Paolo Fabris
DBDave Brown
Dave Brown
GTGiulia Tositti
Giulia Tositti
LBLoredana Bozzola
Loredana Bozzola
MGMariaTeresa Giordani
MariaTeresa Giordani
GDGeoffrey Dusheiko
Geoffrey Dusheiko

1 March 2004 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
AMAnnarosa Del Mistro
Annarosa Del Mistro
RBRoberta Bertorelle
Roberta Bertorelle
MFMarzia Franzetti
Marzia Franzetti
ACANNA MARIA CATTELAN
ANNA MARIA CATTELAN
ATAngela Torrisi
Angela Torrisi
LCLuigi Chieco‐Bianchi
Luigi Chieco‐Bianchi
The effect of antiretroviral therapy on the natural history of human papillomavirus (HPV)–associated genital lesions was evaluated in 201 human immun

18 January 2016 in Current Infectious Disease Reports
Verified
Journal Article
Closed access
PDF file
EBEnrico Brunetti
Enrico Brunetti
THTom Heller
Tom Heller
JRJoachim Richter
Joachim Richter
DKDaniel Kaminstein
Daniel Kaminstein
DYDaniel Youkee
Daniel Youkee
FTFrancesca Tamarozzi
Francesca Tamarozzi

7 June 2017 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
FTFrancesca Tamarozzi
Francesca Tamarozzi
FVFreddy Vilca
Freddy Vilca
RBRuben Bascope
Ruben Bascope
AHAmy Hou
Amy Hou
EBEnrico Brunetti
Enrico Brunetti
MMMaria Luisa Morales
Maria Luisa Morales
Latin America is among the highly endemic regions for cystic echinococcosis (CE). In Peru, an estimated 1,139 disability-adjusted life years are lost annually from surgical treatment of CE. This is comparable with the combined total for Argentina, Brazil, Uruguay, and Chile. The prevalence of human infection has been investigated in the central Peruvian Andes, but there are no community-based screening data from other regions of Peru. We carried out a population survey in January 2015 using abdominal ultrasound to estimate the prevalence of abdominal CE in the Canas and Canchis provinces, in the Cusco region of Peru. Among 1,351 subjects screened, 41 (3%) had CE. There was significant variation between communities with similar socioeconomic features in a small geographical area. A history of CE was reported by 4.1% of the screened subjects, among whom 30.3% still had CE on ultrasound. Among patients reporting previous CE treatment, 14.9% had CE in active stages. Limited education, community of residence, and knowing people with CE in the community were associated with CE. These results demonstrate a significant burden of CE in the region and suggest the need for further investigations, control activities, and optimization of clinical management for CE in this area.